Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
22.05.2024 - Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that three submitted ...
Source: wallstreet-online.de